Pharm D Solutions Recalls Testosterone Cyp/Pro Vials for Sterility Concerns
Pharm D Solutions is recalling 371 vials of Testosterone Cyp/Pro 95/5% due to a lack of sterility assurance. The affected prescription medication was distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. According to the rubric, FDA Class II recalls involving significant risks such as sterility issues in injectable medications are categorized as Severe.
Plain-English summary
Pharm D Solutions, LLC is recalling 371 vials of Testosterone Cyp/Pro 95/5%, 10 mL vials, which are prescription-only medication. The recall was initiated because of a lack of sterility assurance in the product.
The affected product was distributed nationwide within the United States. The recall covers specific lots with expiration dates of August 16, 2019, and November 30, 2019.
Consumers who have this product should stop using it and contact Pharm D Solutions at 1-844-263-6846 for further instructions.
The recalled product
- Product
- Testosterone Cyp/Pro 95/5%, 10 mL vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846
- Manufacturer
- Pharm D Solutions, LLC
- Category
- Drug — Injectable Steroid
- Hazard
- Affected units
- 371
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 01312019:02 Exp. 08/16/2019
- 02072019:45/A Exp. 11/30/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · Pharm D Solutions, LLC
See all →- SeverePharm D Solutions Recalls Sermorelin/GHRP-2 &6 Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Sermorelin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereFDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15